L-Carnosine
Also sold as: Carnosine
Best-in-class: L-Carnosine
A dipeptide (beta-alanine + histidine) that fights glycation — the sugar-driven 'caramelization' of proteins that accelerates aging — plus antioxidant and brain support.
L-Carnosine quick facts
| Suggested dose | 500–1,000 mg daily. |
| How often | Daily |
| Who it's for | Anti-glycation/anti-aging, eye and brain support. |
The anti-glycation mechanism is elegant and the delivery problem is serious — most oral carnosine is degraded before it reaches tissue, which is precisely why beta-alanine is used instead to raise muscle carnosine from the inside. As an anti-ageing intervention the mechanism is better than the evidence. Carnosinase activity varies genetically, so response probably varies more than the trials capture.
How L-Carnosine actually works
A dipeptide of beta-alanine and histidine that acts as a sacrificial anti-glycating agent — it reacts with reactive carbonyls so your structural proteins do not, preventing advanced glycation end-product formation. It also chelates transition metals and buffers pH in muscle. The obstacle is serum carnosinase, which cleaves it within minutes of absorption.
Where to get L-Carnosine
Find L-Carnosine on iHerb →The evidence for L-Carnosine
Graded by what exists behind each claim.
✅ Clinically validated
- Anti-glycation and antioxidant activity in studies; researched for eye (cataract), skin-aging and cognition.
- Buffers and protects tissues under oxidative/glycative stress.
📊 Correlative data
- Concentrations in human muscle and brain fall measurably with age, and are higher in populations with high meat intake — vegetarians run notably lower. Both are observations about status rather than evidence that supplementing changes outcomes.
🧪 Theoretical / extrapolated benefits
- Anti-aging via glycation control is compelling mechanistically; human longevity outcomes are early.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What L-Carnosine actually does
Carnosine is beta-alanyl-L-histidine, and the beta is the most consequential letter on this page. In every protein you own the amide bond joins an alpha-amino group to a carboxyl; here the amine comes off the beta carbon of alanine instead. Ordinary aminopeptidases cannot cleave that bond, which is why evolution had to build a dedicated enzyme to destroy it — and why the story of supplementing carnosine is really the story of that enzyme.
The enzyme is serum carnosinase, CN1, gene CNDP1. It is a secreted metallopeptidase circulating in human plasma, and the critical comparative fact is that humans are the outlier: mice and rats have essentially no serum carnosinase activity. Human serum carnosinase activity has been measured in patients with type 2 diabetes at 2.53 ± 1.1 micromoles per milliliter per hour without nephropathy and 1.25 ± 0.5 with it, with serum CNDP1 protein at 51.2 ± 17.6 against 30.4 ± 18.3 micrograms per milliliter (P < 0.05 for both) Zhang 2019. Those numbers matter because they describe several-fold variation between individuals in the rate at which the supplement you just swallowed is taken apart.
And it is partly genetic. CNDP1 carries a trinucleotide repeat in its signal peptide that encodes a run of leucines, and the short-repeat homozygous genotype tracks with lower enzyme secretion — the genotype counted in that same diabetic cohort Zhang 2019. So carnosine is one of a very small number of supplements whose response should be predictable from a single genotype, and no trial has ever used it that way.
Where carnosine hides, and it is a real finding. Red blood cells protect carnosine from serum carnosinase Oppermann 2021. CN1 is extracellular; carnosine taken up into the erythrocyte is out of its reach. That single fact reframes the pharmacokinetics: plasma carnosine is not the compartment to measure, whole blood is, and studies that report rapid disappearance from serum may be watching partition rather than destruction.
What carnosine actually does when it survives, named chemically. It is a carbonyl quencher, not a radical scavenger. Its imidazole ring and free amine react directly with reactive carbonyl species — methylglyoxal, glyoxal, acrolein, 4-hydroxynonenal — forming stable adducts and consuming the electrophile before it can cross-link a lysine or arginine residue on a long-lived protein. That is the anti-glycation mechanism, and it is sacrificial: each molecule works once. It also chelates copper and zinc, and buffers protons in the pH range that matters in contracting muscle Cesak 2023.
Cell, rodent, human — and where it stops
In cells. Carnosine at millimolar concentrations preventing carbonyl-driven protein cross-linking. Millimolar is not a typo: this is a stoichiometric quencher rather than a catalyst, so it has to be present in the same order of magnitude as the carbonyl load. Human skeletal muscle holds carnosine at millimolar concentrations naturally; human plasma does not, and cannot.
In rodents, and this is the translational trap. The genetic evidence that carnosine matters is strong — knocking out carnosinase-1 reduces kidney fibrosis in type-1 diabetic mice on a high-fat diet Pfeffer 2023. But mice barely express serum carnosinase to begin with. Every rodent carnosine-supplementation study is therefore conducted in an animal that lacks the enzyme which in a human destroys the dose. That is not a minor species difference; it is the single reason this literature does not transfer, and it is almost never stated on a label.
In people, and the results split by endpoint. On glycemia the pooled analysis of 20 studies — 4 human, 16 rodent — found fasting glucose lower with carnosine or beta-alanine supplementation, by a mean difference of 0.95 mmol/L in humans and 2.26 mmol/L in rodents, with HbA1c reduced in both Matthews 2021. On vascular endpoints, 49 patients with prediabetes or type 2 diabetes took 2 g/day for 14 weeks and it changed nothing: not heart rate, not blood pressure, not endothelial function, not arterial stiffness, not lipids, not renal outcomes Saadati 2023. On performance, five subjects taking 20 mg/kg each of carnosine and anserine before exercise gained 6% ± 11% in peak power over the first five seconds of a Wingate test — 12.8 ± 2.4 against 12.1 ± 2.2 W/kg, P = 0.04 Blancquaert 2021.
Read those three together and a shape appears. The fast, acute, buffering-type endpoint moved in five people. The slow vascular endpoints did not move in 49 people over 14 weeks. That is consistent with a molecule that transiently raises a buffer and is then cleared, and inconsistent with one that accumulates and remodels tissue — which is exactly what the carnosinase biology predicts Zhang 2019.
The obstacle stated plainly. Oral carnosine is substantially hydrolyzed to beta-alanine and histidine, and beta-alanine is the rate-limiting precursor for the body's own carnosine synthesis Cesak 2023. So a large fraction of what a carnosine capsule achieves, it achieves as an expensive beta-alanine capsule.
L-Carnosine — which form, and does it matter
Carnosine, beta-alanine, anserine and zinc-carnosine are four products and they are not interchangeable. Beta-alanine is the precursor and the cheapest reliable way to raise muscle carnosine. Anserine is methylated carnosine — beta-alanyl-1-methylhistidine — and the methyl group changes how carnosinase handles it, which is why the acute performance study used the two together Blancquaert 2021. Zinc-carnosine (polaprezinc) is a coordination polymer used for gastric mucosal protection and is a different product for a different organ.
The dose that has been tested is 2 g/day, and the site's card says 500–1,000 mg. The 14-week vascular trial used 2 g/day and found nothing Saadati 2023; the acute performance work used 20 mg/kg, which is about 1.4 g for a 70 kg adult Blancquaert 2021. A 500 mg capsule is below both. That is worth knowing before concluding a product does not work.
Timing is not cosmetic here, it is the pharmacokinetics. Carnosine is cleared from plasma quickly by carnosinase Zhang 2019, so an acute effect needs the dose close to the event — the performance study dosed pre-exercise Blancquaert 2021. For a chronic anti-glycation goal the logic reverses: sustained low exposure across the day beats one large peak, because carbonyl generation is continuous. Split dosing follows from the mechanism rather than from habit.
N-acetylcarnosine eye drops are a separate product that shares a name. The cataract literature concerns a topical prodrug applied to the eye, not an oral capsule, and no oral carnosine trial has ever used a lens endpoint. Buying capsules for cataract is buying the wrong route of administration.
What would have to be true, and how you would know it was not
1. Fasting glucose down 5–15 mg/dL at 12 weeks on 2 g/day, in dysglycemic people only. The pooled human estimate is a 0.95 mmol/L reduction, which is about 17 mg/dL Matthews 2021. Predict essentially nothing in someone with a normal fasting glucose — there is no room, and none of the pooled studies were run in the normoglycemic.
2. HbA1c down 0.2–0.4 percentage points at 12 weeks. The window is not arbitrary: HbA1c reflects the preceding red-cell lifespan, so 12 weeks is the earliest a change is fully expressed Matthews 2021. Measuring it at four weeks is measuring the previous quarter.
3. The prediction that cuts against the product, and it has already been run. Arterial stiffness, endothelial function, blood pressure and the lipid panel will not move. Forty-nine people, 2 g/day, 14 weeks, nothing on any of them Saadati 2023. If you are buying carnosine as a vascular anti-aging intervention, the only trial that measured vascular anti-aging endpoints found none. Predict pulse wave velocity unchanged at six months.
4. The most elegant falsification on this page: paraesthesia is evidence of failure, not of potency. If you feel the beta-alanine tingle 20–40 minutes after a carnosine dose, that tingle is histaminergic-independent paraesthesia caused by free beta-alanine — which means the dipeptide was hydrolyzed before it did anything as a dipeptide Cesak 2023. Predict that people who tingle are high-carnosinase individuals Zhang 2019, and that they are the people for whom oral carnosine is least likely to work as carnosine. A symptom that most readers take as proof the product is active is, on this mechanism, proof of the opposite.
What nobody has tested yet
No carnosine trial has ever been stratified by carnosinase activity or CNDP1 genotype. This is the experiment. Serum carnosinase activity varies roughly two-fold between individuals and is measurable in a routine assay Zhang 2019. Measure it at baseline, split the cohort at the median, then run the same 14-week protocol that produced a null Saadati 2023 within each stratum. If the effect lives in the low-carnosinase half, every trial averaging across both has been diluting itself to nothing, and the product needs a companion test rather than a bigger dose.
Nobody has co-administered a carnosinase inhibitor. Such compounds are in development precisely because CN1 is a drug target Cesak 2023Pfeffer 2023. The proof-of-concept experiment — carnosine alone, inhibitor alone, both together, whole-blood carnosine as the endpoint — would establish in one crossover whether oral carnosine can be made to work at all in a human.
Skin autofluorescence has never been used as an endpoint. It is a non-invasive optical measure of accumulated advanced glycation end-products in the dermis, it takes 12 seconds, and it is the closest thing to a direct read-out of the anti-glycation claim this product is sold on. Twelve months of 2 g/day with skin autofluorescence measured quarterly is a cheap trial nobody has run.
And nobody has compared oral carnosine with equimolar beta-alanine. Same participants, same molar dose of beta-alanine equivalents, four weeks, muscle carnosine by magnetic resonance spectroscopy Cesak 2023. If the two are equivalent, carnosine is an expensive beta-alanine and the page should say so. If carnosine wins, the intact dipeptide is reaching tissue and the carnosinase objection is weaker than it looks. It is a four-week study and it would settle a twenty-year argument.
L-Carnosine — its own safety story, not its category's
The paraesthesia is real, it is the beta-alanine, and it is dose-dependent. Carnosine hydrolyzes to beta-alanine and histidine Cesak 2023, and free beta-alanine produces the same tingling of the face, scalp and forearms that a pre-workout supplement does. It is harmless and self-limiting within about an hour. Splitting the dose and taking it with food flattens the peak that causes it.
The histidine half deserves a mention nobody gives it. Hydrolysis liberates L-histidine, which is the substrate for histidine decarboxylase and therefore the direct precursor of histamine. At 2 g/day of dipeptide Saadati 2023 that is a non-trivial daily histidine load. In anybody with histamine intolerance, chronic urticaria or mast cell activation, flushing and headache after dosing have a plausible mechanism here rather than being idiosyncratic, and the test is simply to stop and rechallenge.
Metal chelation is the long-term question and it is genuinely unanswered. Carnosine chelates copper and zinc — the property polaprezinc is built on. Nobody has measured serum copper, ceruloplasmin or zinc after a year of 2 g/day, and a stoichiometric chelator taken daily for years is exactly the situation where a slow mineral drift would go unnoticed. If you take this indefinitely, put zinc and copper on a panel once a year.
Glucose, additive rather than alternative. The pooled evidence has fasting glucose and HbA1c falling Matthews 2021. On insulin or a sulfonylurea that is additive, and the answer is a meter in the first fortnight. Against that, the best-controlled vascular trial found no effect on blood pressure or lipids at all Saadati 2023, so the interaction risk is narrower than the category warning implies — it is glycemic, and it is not cardiovascular.
The honest boundary. Fourteen weeks in 49 people is the longest controlled human exposure with hard endpoints Saadati 2023. There is no long-term data, the anti-aging claim has no human outcome behind it, and anyone quoting a safe ten-year dose is quoting a habit.
Sources read for this page
- Zhang S, et al. Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.. Amino Acids 2019 · PMID 30610469
- Oppermann H, et al. Erythrocytes Prevent Degradation of Carnosine by Human Serum Carnosinase.. International Journal of Molecular Sciences 2021 · PMID 34884603
- Blancquaert L, et al. Acute preexercise supplementation of combined carnosine and anserine enhances initial maximal power of Wingate tests in humans.. Journal of Applied Physiology 2021 · PMID 33914660
- Saadati S, et al. Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial. Nutrients 2023 · PMID 38004228
- Matthews JJ, et al. Effect of Carnosine or beta-Alanine Supplementation on Markers of Glycemic Control and Insulin Resistance in Humans and Animals: A Systematic Review and Meta-analysis. Advances in Nutrition 2021 · PMID 34333586
- Cesak O, et al. Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment. Nutrients 2023 · PMID 37049610
- Pfeffer T, et al. Carnosinase-1 Knock-Out Reduces Kidney Fibrosis in Type-1 Diabetic Mice on High Fat Diet. Antioxidants (Basel) 2023 · PMID 37372000
How you would know if it worked
Glycation is the mechanism, and glycated hemoglobin is a glycation product you can count — which makes this one of the very few anti-aging claims with a direct and cheap read-out. HbA1c is the three-month version, fructosamine the two-to-three-week version, and running both tells you whether something changed recently or whether you are reading an average that has not caught up yet. Expect small movement at most: carnosine scavenges the reactive carbonyls that drive glycation, it does not lower blood sugar, so a large HbA1c drop points at your diet rather than at the capsule.
- HbA1c (Hemoglobin A1c) Retest: Every 3 months (matches red cell lifespan).
- Fructosamine Retest: Every 3–4 weeks during active intervention.
The cheapest panel carrying HbA1c (Hemoglobin A1c) and at least one other of these is Insulin Resistance Deep Dive, at $132 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
L-Carnosine — safety & side effects
- Well tolerated; GI upset at higher doses.
- It is broken down to beta-alanine and histidine, so it can cause the same paraesthesia tingling as beta-alanine at higher doses.
- No significant drug interactions. Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — L-Carnosine in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside L-Carnosine
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation these are aimed at |
| ApoB (Apolipoprotein B) | Cardiovascular risk, measured properly |
| HbA1c (Hemoglobin A1c) | Glycation over three months |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
L-Carnosine — frequently asked questions
What is L-Carnosine?
A dipeptide (beta-alanine + histidine) that fights glycation — the sugar-driven 'caramelization' of proteins that accelerates aging — plus antioxidant and brain support.
What is the suggested dose of L-Carnosine?
500–1,000 mg daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find L-Carnosine dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy L-Carnosine?
Coach Cam sources L-Carnosine from vetted, top-rated brands on iHerb — use the buy link on this page.
What L-Carnosine is used for
L-Carnosine appears under 1 goal in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.